Sagility Limited announced that its Board of Directors approved an acquisition by its step-down subsidiary, Sagility LLC, during their meeting held on June 11, 2026.

Transaction Details

Sagility LLC signed a definitive agreement on June 11, 2026 to acquire 100% of Careseed LLC (CareSeed), a US-based healthcare analytics and technology company.

Target Company Information

  • Name: Careseed LLC (CareSeed)
  • Industry: USA Healthcare analytics and technology
  • Business: Provides quality measurement (HEDIS) reporting and risk adjustment solutions through an NCQA-certified cloud-based platform
  • Incorporation: 2012
  • Headquarters: Kansas City, United States
  • Financial Performance:
  • CY2023 Turnover: USD 3.6 million
  • CY2024 Turnover: USD 4.0 million
  • CY2025 Turnover: USD 5.1 million

Transaction Structure

  • Consideration: Cash payment subject to customary closing adjustments
  • Additional Consideration: Contingent payment of up to USD 12.5 million payable subject to achievement of revenue growth synergies
  • Shareholding: 100% acquisition

Strategic Rationale

The acquisition aligns with Sagility's strategy to strengthen its healthcare analytics capabilities and expand into quality measurement and risk adjustment solutions. Specifically:

  • Adds a proven, NCQA-certified HEDIS reporting platform
  • Provides presence among 30 mid-sized U.S. health plans
  • Enhances Sagility's position in the payer ecosystem
  • Enables expansion into STAR performance management and care gap closure services
  • Creates opportunities to cross-sell integrated technology and service offerings
  • Aims to drive improved quality outcomes and operational efficiency for clients

Regulatory Aspects

  • Related Party Transaction: No
  • Governmental/Regulatory Approvals Required: None (NA)
  • Completion Timeline: June 11, 2026 (indicative time-period)

Compliance Information

The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the specified SEBI circular.

#Sagility #M&A #SEBIDisclosure #RegulatoryCompliance #StrategicAcquisition #Neutral